Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve 1.To consider and approve the Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medi Caps Ltd has informed the BSE that its Board of Directors will meet on Wednesday, 11 February 2026 at its registered office in Indore. The main agenda is to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter and nine months ended 31 December 2025, along with the Limited Review Report from the auditors. No actual financial numbers have been shared in this filing — it is only a prior intimation of the upcoming board meeting. The company also reminded that the trading window for insiders will reopen only 48 hours after the results are officially declared.
This is a routine pre-results announcement with no direct impact on the stock. Investors should watch for the actual Q3 FY26 results on or shortly after 11 February 2026, which could move the stock depending on performance versus expectations. The trading window closure means company insiders cannot trade until results are out.